In a report released today, George Kelly from Roth MKM reiterated a Buy rating on biote (BTMD – Research Report), with a price target of ...

Roth MKM analyst Justin Clare maintained a Buy rating on Atkore International Group (ATKR – Research Report) today and set a price target of ...

Roth/MKM analysts reinstated coverage on PLBY Group, Inc. (NASDAQ: PLBY) with a Buy rating and set a price target of $3.00, ...

We recently compiled a list of the 10 AI News Updates Trending on Wall Street. In this article, we are going to take a look ...

Roth/MKM analysts adjusted their outlook on Intel Corporation (NASDAQ:INTC) by reducing the stock's price target from $25.00 to $20.00, while continuing to hold a Neutral rating on the shares.

Roth Mkm restated their buy rating on shares of TriSalus Life Sciences (NASDAQ:TLSI – Free Report) in a research report ...

Equities research analysts at Roth Capital cut their Q4 2024 EPS estimates for Viper Energy in a report released on Tuesday, January 28th. Roth Capital analyst L. Mariani now anticipates that the oil ...

Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 37.32% ...

Fintel reports that on January 23, 2025, Roth MKM initiated coverage of Innventure (NasdaqGM:INV) with a Buy recommendation. What are Other Shareholders Doing? Legacy Bridge holds 7K shares ...

Stock Trading Recap. On Friday, Reviva Pharmaceuticals Holdings Inc (RVPH) stock saw a decline, ending the day at $1.77 which represents ...

Fintel reports that on January 21, 2025, Roth MKM initiated coverage of Synergy CHC (NasdaqCM:SNYR) with a Buy recommendation. What is the Fund Sentiment? There are 2 funds or institutions ...